Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease. Adjuvante Therapie von Melanompatienten im Stadium III mit einer Kombination aus Newcastle-disease-Virus-modifiziertem Tumorzelllysat und Interleukin-2

2003 ◽  
Vol 1 (2) ◽  
pp. 120-125 ◽  
Author(s):  
Christiane Voit1 ◽  
Martina Kron2 ◽  
Markus Schwurzer-Voit1 ◽  
Wolfram Sterry1
Keyword(s):  
Newcastle Disease Virus ◽  
Disease Virus ◽  
Melanoma Cell ◽  
Adjuvant Treatment ◽  
Newcastle Disease ◽  
Adjuvante Therapie ◽  
Interleukin 2 ◽  
Intradermal Injection ◽  
Cell Lysate ◽  
Melanoma Patients

Response of the Syrian Hamster to Intradermal Injection of Modified Newcastle Disease Virus

1949 ◽  
Vol 72 (1) ◽  
pp. 163-165 ◽  
Author(s):  
R. L. Reagan ◽  
H. O. Werner ◽  
J. W. Hartley ◽  
D. M. Schenk ◽  
A. L. Brueckner
Keyword(s):  
Newcastle Disease Virus ◽  
Disease Virus ◽  
Newcastle Disease ◽  
Syrian Hamster ◽  
Intradermal Injection

scholarly journals Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy

2014 ◽  
Vol 15 (9) ◽  
pp. 1226-1238 ◽  
Author(s):  
Fu-Liang Bai ◽  
Yin-Hang Yu ◽  
Hui Tian ◽  
Gui-Ping Ren ◽  
Hui Wang ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Newcastle Disease Virus ◽  
Disease Virus ◽  
Newcastle Disease ◽  
Interleukin 2 ◽  
Genetically Engineered

Characterization of Recent Isolates of Newcastle Disease virus

2016 ◽  
Vol 21 (1) ◽  
pp. 235-248
Author(s):  
Amani Saleh ◽  
Rola Ali ◽  
Mohamed Fawzy ◽  
Mokhtar Eltarabily
Keyword(s):  
Newcastle Disease Virus ◽  
Disease Virus ◽  
Newcastle Disease
Sign in / Sign up

Export Citation Format

Share Document